Abstracts
| Adult Epileptology |
| Basic science |
| Clinical Neurophysiology |
| Comorbidities |
| Drug Therapy |
| Epidemiology |
| Epilepsy and Reproductive Health |
| Epilepsy in Older People |
| Epilepsy in Resource-restricted Settings |
| Epilepsy Surgery |
| Genetics |
| Neuroimaging |
| Neuropsychology |
| Neurostimulation |
| Nursing |
| Paediatric Epileptology |
| Pandemic Response |
| Psychiatry |
| Social Issues |
| Status Epilepticus |
| Terminology and Classification |
Abstract Submission Rules
1. Abstracts will not be accepted unless they are submitted online via the online abstract submission system before midnight (GMT) on the deadline date. Abstracts received after this date will NOT be accepted. Abstracts submitted by post, fax or email will NOT be considered.
2. All abstracts should be written, submitted and presented in English with a maximum word count of 300 words (not including the abstract title, authors and institutions).
3. Authors will be notified in writing as to whether or not their abstract has been accepted by the Abstract Review Committee. The decision of the committee is final and no correspondence will be entered into.
4. Once an abstract has been accepted, the presenting author must register for the congress for final acceptance. An abstract presenter may not register as a day delegate.
5. Instructions fwill be available on the congress website.
6. All correspondence will be sent to the submitting author only. It is the responsibility of the submitting author to forward any relevant correspondence to the presenting author.
Abstract Content Rules
1. Abstract submitters should ensure that the final version is submitted by the deadline; changes will not be permitted once the deadline has passed.
2. Institution information should be provided for all authors. Please include institution, city, state/ province and country but exclude department, division, laboratory, etc.
3. A topic category for each abstract must be selected during the submission process.
4. Abstracts should be structured in 4 sections as follows:
- Purpose: Should indicate the objectives of the work being presented.
- Method: Should describe study material or subjects (e.g. number and type of patients), intervention and evaluation procedures.
- Results: Should summarize the main findings. Wherever possible, give numerical values, including means with SD or SEM, and statistical significance or confidence intervals.
- Conclusion: Should state briefly the conclusions reached in the work.
5. Figures, tables and other illustrations may not be included.
6. If the work was supported by funds provided by a commercial organisation this should be stated in a short acknowledgment at the end of the abstract. Other sources of funding may be acknowledged in the same way.
7. Submission of multiple abstracts describing different components of the same study is not appropriate. All findings generated from the same study should be included in a single abstract.
8. Abstracts containing single case reports will not usually be accepted, unless the report is of outstanding scientific or clinical interest because of the uniqueness of the findings or the sophistication of the investigations.
9. Abstracts containing data considered to be insufficiently informative will not be accepted.
10. Authors should use a concise title that indicates the content of the abstract. Abbreviations should be avoided in the title.
11. For intervention studies (for example, therapeutic trials), type of design (prospective or retrospective, controlled or uncontrolled, randomized or observational, open vs. single-blind vs. double-blind), dosages, assessment methods and duration of follow-up should be specified.
12. Non-proprietary names of drugs must be used throughout. If results are considered to be specific for a given proprietary product (for example, bio-equivalence studies), the non-proprietary name must still be used, followed by the proprietary name and the name of the manufacturers in brackets.
13. Abbreviations should be used sparingly. For words that are abbreviated, use the whole term the first time, followed by the standard abbreviation in parenthesis.
14. References should be used sparingly. They should be included within the text in brackets. For journals, mention first author “et al”, followed by the name of the journal as abbreviated in the Index Medicus, year, volume number and inclusive pages (e.g. Hardus P et al. Epilepsia 2001;42:262-267.). For book chapters, give first author “et al”, editor, title, publisher, city of publication, year and inclusive pages (e.g. Levy RH et al. In: Levy RH et al, Antiepileptic Drugs. Lippincott-Raven, 1996;13-30.).
15. Submission of an abstract automatically implies acknowledgment that the work described was conducted in accordance with current ethical standards and regulations in biomedical research. Failure to adhere to these standards will result in rejection of the abstract.
ABSTRACT SUBMISSION
How do I submit an abstract?
Abstracts will only be accepted for review if submitted via the congress abstract submission system which will open shortly.
Can I make changes to my abstract after submission?
You may make changes to your submitted abstract until the official submission deadline.
Once the abstract submission deadline has passed, changes are not permitted unless they relate to the results of the study. In this case only, please contact abstracts@epilepsycongress.org.
Can I submit an abstract after the deadline?
Abstracts will not be accepted for review after the deadline. Please contact abstracts@epilepsycongress.org with any queries.
Can an Encore Abstract be submitted?
Yes an encore abstract may be submitted, provided that there is no copyright issue with the original publisher.
What is the abstract word count?
Maximum word count is 300.
ABSTRACT ACCEPTANCE
When will I know if my abstract has been accepted?
Authors will be notified of the outcome of the abstract review once completed.
How will I receive the information from the Secretariat?
Contact details provided at the time of submission will be used for all correspondence related to the congress. Please ensure that the correct details are entered.
All correspondence will be sent to the submitting author only. It is the responsibility of the submitting author to forward any relevant correspondence to the presenting author, if different, and any co-authors.
How will my abstract be presented at the congress?
Authors of abstracts which have been accepted for presentation will receive all details by email using the contact details provided at the time of submission.
My colleague has received confirmation of their abstract acceptance and I did not, is there something wrong?
Please contact abstracts@epilepsycongress.org.
ABSTRACTS - GENERAL QUERIES
Which reference number should I use when I send a query to the Secretariat?
The personal ID Reference Number that you received when you submitted your abstract should be mentioned in all correspondence.
I am not the first author; may I present the poster on behalf of my colleagues?
Presentation by a second author may be allowed. Once your registration has been completed, please contact abstracts@epilepsycongress.org. Please note however that each author is permitted to present only once during the congress (not including invited lectures).
Can the presenting author pay one-day registration fee (for the day when the poster is displayed)?
No. Once an abstract has been approved, the presenting author must register for the entire congress for final acceptance. An abstract presenter may not register as a day delegate. Non-registered authors may be excluded from publication.
I am an invited speaker in the congress programme; do I need to submit an abstract?
Invited speakers are not required to submit abstracts to illustrate their talks.
How do I find information about eposters?
All information relating to eposters will be available on the website after the abstract review is completed.
How do I upload my poster? What is the format?
You will receive login details for the poster platform along with instructions on how to upload your poster as a single PDF or single slide in PPT/PPTX format. Your poster must be in landscape orientation, with a screen ratio of 16:9, no larger that 10 Megabytes, and must be in English.
Who can upload my poster?
Only the presenting author can upload the poster. All correspondence will be sent to the presenting author.
I am not the first author; may I present the poster on behalf of my colleagues?
Presentation by a second author may be allowed. Once the presenting author’s registration has been completed, please contact abstracts@epilepsycongress.org to identify the name and email address of the presenting author. Please note however that each author is permitted to present only once during the congress (not including invited lectures).
Will I be able to upload audio and/or video content to my poster?
Yes, however you must upload this content separately. You will upload your poster in the poster section of the platform, and just below that you will see the audio and video section of the platform.
You can upload your audio and video files there. You may upload a maximum on ONE audio file and ONE video file. The file size limit is 100MB. You can upload only the following file types for audio and video: .mp3, .mp4, .wav, .m4a. Each upload may not exceed 3 minutes.
You will not be able to embed audio or video files in your poster section upload.
Can I edit my poster after submitting my poster?
Yes, you can continue to edit your poster until 15 April 2022. You cannot edit your poster in the platform, you must upload an edited version. Any changes made after this date will not be visible in the platform during the congress.
Can congress delegates download my poster during the congress?
Yes. Delegates can download your poster in PDF format throughout the congress and during the on-demand period ending 8 August.
Will I be able to engage with delegates during the congress?
Yes, delegates can comment on the poster in the poster platform and you can respond. Additionally, there is similar function on the congress platform to comment virtually in real time.
The Scientific and Organising Committee would like to extend its gratitude for the assistance of the following people with the review of the abstracts.
|
Taylor Abel (United States) |
Jaideep Kapur (United States) |
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community